☰

Tapas K. Das Gupta - Publications

Affiliations: 
University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Mander S, Naffouje SA, Gao J, Li W, Christov K, Green A, Bongarzone ER, Das Gupta TK, Yamada T. Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy. Frontiers in Oncology. 12: 940001. PMID 35936749 DOI: 10.3389/fonc.2022.940001  0.394
2022 Naffouje SA, Goto M, Coward LU, Gorman GS, Christov K, Wang J, Green A, Shilkaitis A, Das Gupta TK, Yamada T. Nontoxic Tumor-Targeting Optical Agents for Intraoperative Breast Tumor Imaging. Journal of Medicinal Chemistry. PMID 35544687 DOI: 10.1021/acs.jmedchem.2c00417  0.473
2022 Naffouje S, Goto M, Ryoo I, Green A, Das Gupta TK, Yamada T. A Method of Tumor In Vivo Imaging with a New Peptide-Based Fluorescent Probe. Methods in Molecular Biology (Clifton, N.J.). 2394: 857-865. PMID 35094362 DOI: 10.1007/978-1-0716-1811-0_45  0.371
2016 Yamada T, Das Gupta TK, Beattie CW. p28-mediated Activation of p53 in G2/M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy. Cancer Research. PMID 26921335 DOI: 10.1158/0008-5472.Can-15-2355  0.46
2013 Yamada T, Das Gupta TK, Beattie CW. p28, an anionic cell-penetrating peptide, increases the activity of wild type and mutated p53 without altering its conformation. Molecular Pharmaceutics. 10: 3375-83. PMID 23952735 DOI: 10.1021/mp400221r  0.402
2013 Turner A, Li LC, Pilli T, Qian L, Wiley EL, Setty S, Christov K, Ganesh L, Maker AV, Li P, Kanteti P, Das Gupta TK, Prabhakar BS. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells. Plos One. 8: e56817. PMID 23457619 DOI: 10.1371/Journal.Pone.0056817  0.446
2011 Mehta RR, Yamada T, Taylor BN, Christov K, King ML, Majumdar D, Lekmine F, Tiruppathi C, Shilkaitis A, Bratescu L, Green A, Beattie CW, Das Gupta TK. A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt. Angiogenesis. 14: 355-69. PMID 21667138 DOI: 10.1007/S10456-011-9220-6  0.427
2011 Jia L, Gorman GS, Coward LU, Noker PE, McCormick D, Horn TL, Harder JB, Muzzio M, Prabhakar B, Ganesh B, Das Gupta TK, Beattie CW. Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemotherapy and Pharmacology. 68: 513-24. PMID 21085965 DOI: 10.1007/S00280-010-1518-3  0.449
2010 Mehta RR, Hawthorne M, Peng X, Shilkaitis A, Mehta RG, Beattie CW, Das Gupta TK. A 28-amino-acid peptide fragment of the cupredoxin azurin prevents carcinogen-induced mouse mammary lesions. Cancer Prevention Research (Philadelphia, Pa.). 3: 1351-60. PMID 20841487 DOI: 10.1158/1940-6207.Capr-10-0024  0.481
2009 Yamada T, Mehta RR, Lekmine F, Christov K, King ML, Majumdar D, Shilkaitis A, Green A, Bratescu L, Beattie CW, Das Gupta TK. A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Molecular Cancer Therapeutics. 8: 2947-58. PMID 19808975 DOI: 10.1158/1535-7163.Mct-09-0444  0.492
2009 Kwan JM, Fialho AM, Kundu M, Thomas J, Hong CS, Das Gupta TK, Chakrabarty AM. Bacterial proteins as potential drugs in the treatment of leukemia Leukemia Research. 33: 1392-1399. PMID 19250673 DOI: 10.1016/J.Leukres.2009.01.024  0.423
2009 Taylor BN, Mehta RR, Yamada T, Lekmine F, Christov K, Chakrabarty AM, Green A, Bratescu L, Shilkaitis A, Beattie CW, Das Gupta TK. Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Research. 69: 537-46. PMID 19147567 DOI: 10.1158/0008-5472.CAN-08-2932  0.617
2007 Fialho AM, Stevens FJ, Das Gupta TK, Chakrabarty AM. Beyond host-pathogen interactions: microbial defense strategy in the host environment. Current Opinion in Biotechnology. 18: 279-86. PMID 17451932 DOI: 10.1016/J.Copbio.2007.04.001  0.379
2007 Lekmine F, Chang CK, Sethakorn N, Das Gupta TK, Salti GI. Role of microphthalmia transcription factor (Mitf) in melanoma differentiation. Biochemical and Biophysical Research Communications. 354: 830-5. PMID 17266927 DOI: 10.1016/j.bbrc.2007.01.075  0.333
2007 Chaudhari A, Mahfouz M, Fialho AM, Yamada T, Granja AT, Zhu Y, Hashimoto W, Schlarb-Ridley B, Cho W, Das Gupta TK, Chakrabarty AM. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth. Biochemistry. 46: 1799-810. PMID 17249693 DOI: 10.1021/Bi061661X  0.468
2007 Mahfouz M, Hashimoto W, Das Gupta TK, Chakrabarty AM. Bacterial proteins and CpG-rich extrachromosomal DNA in potential cancer therapy. Plasmid. 57: 4-17. PMID 17166586 DOI: 10.1016/J.Plasmid.2006.11.001  0.543
2006 Vijayakumar S, Boerner PS, Mehta RR, Packianathan S, Mehta RG, Das Gupta TK. Clinical trials using chemopreventive vitamin D analogs in breast cancer. Cancer Journal (Sudbury, Mass.). 12: 445-50. PMID 17207311 DOI: 10.1097/00130404-200611000-00001  0.324
2006 Hong CS, Yamada T, Hashimoto W, Fialho AM, Das Gupta TK, Chakrabarty AM. Disrupting the entry barrier and attacking brain tumors: the role of the Neisseria H.8 epitope and the Laz protein. Cell Cycle (Georgetown, Tex.). 5: 1633-41. PMID 16861907 DOI: 10.4161/cc.5.15.2991  0.342
2005 Hiraoka Y, Granja AT, Fialho AM, Schlarb-Ridley BG, Das Gupta TK, Chakrabarty AM, Yamada T. Human cytochrome c enters murine J774 cells and causes G1 and G2/M cell cycle arrest and induction of apoptosis. Biochemical and Biophysical Research Communications. 338: 1284-90. PMID 16256942 DOI: 10.1016/J.Bbrc.2005.10.078  0.316
2004 Peng X, Maruo T, Cao Y, Punj V, Mehta R, Das Gupta TK, Christov K. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells. Cancer Research. 64: 8911-8. PMID 15604252 DOI: 10.1158/0008-5472.CAN-04-1810  0.382
2004 Yamada T, Hiraoka Y, Das Gupta TK, Chakrabarty AM. Rusticyanin, a bacterial electron transfer protein, causes G1 arrest in J774 and apoptosis in human cancer cells. Cell Cycle (Georgetown, Tex.). 3: 1182-7. PMID 15467448  0.341
2004 Yamada T, Hiraoka Y, Das Gupta TK, Chakrabarty AM. Regulation of mammalian cell growth and death by bacterial redox proteins: relevance to ecology and cancer therapy. Cell Cycle (Georgetown, Tex.). 3: 752-5. PMID 15153808  0.533
2004 Hiraoka Y, Yamada T, Goto M, Das Gupta TK, Chakrabarty AM. Modulation of mammalian cell growth and death by prokaryotic and eukaryotic cytochrome c. Proceedings of the National Academy of Sciences of the United States of America. 101: 6427-32. PMID 15082831 DOI: 10.1073/pnas.0401631101  0.37
2004 Yamada T, Hiraoka Y, Ikehata M, Kimbara K, Avner BS, Das Gupta TK, Chakrabarty AM. Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurin. Proceedings of the National Academy of Sciences of the United States of America. 101: 4770-5. PMID 15044691 DOI: 10.1073/Pnas.0400899101  0.49
2004 Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, Graves J, Yamada T, Constantinou AI, Christov K, White B, Li G, Majumdar D, Chakrabarty AM, Das Gupta TK. Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene. 23: 2367-78. PMID 14981543 DOI: 10.1038/Sj.Onc.1207376  0.582
2003 Punj V, Das Gupta TK, Chakrabarty AM. Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53. Biochemical and Biophysical Research Communications. 312: 109-14. PMID 14630027 DOI: 10.1016/J.Bbrc.2003.09.217  0.509
2003 Kichina JV, Rauth S, Das Gupta TK, Gudkov AV. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53. Oncogene. 22: 4911-7. PMID 12894234 DOI: 10.1038/Sj.Onc.1206741  0.364
2003 Gentile MS, Vasu C, Green A, Murillo G, Das Gupta TK, Constantinou AI, Prabhakar BS, Salti GI. Targeting colon cancer cells with genistein-17.1A immunoconjugate. International Journal of Oncology. 22: 955-9. PMID 12684659 DOI: 10.3892/Ijo.22.5.955  0.395
2002 Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, Majumdar D, Cunningham E, Das Gupta TK, Chakrabarty AM. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proceedings of the National Academy of Sciences of the United States of America. 99: 14098-103. PMID 12393814 DOI: 10.1073/Pnas.222539699  0.645
Show low-probability matches.